What lies in the near future for the treatment of rheumatoid arthritis?

Reumatol Clin. 2017 Sep-Oct;13(5):249-251. doi: 10.1016/j.reuma.2017.04.001. Epub 2017 May 9.

[Article in English, Spanish]

Authors

Hèctor Corominas¹, Robert H Shmerling²

Affiliations

¹ Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Servei de Reumatologia, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain. Electronic address: vancor@yahoo.com.
² Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

PMID: 28495361
DOI: 10.1016/j.reuma.2017.04.001

No abstract available

Publication types

Editorial

MeSH terms

Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Drug Therapy, Combination
Humans
Rheumatology / methods
Rheumatology / trends*

Substances

Antirheumatic Agents